LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Which stock market is best: the UK or US? Here’s how British investors can benefit regardless
Investing Articles
This UK share’s outperforming Nvidia. Is it time to buy?
Investing Articles
Are these 2 of the most profitable UK stocks on the FTSE 100? My money says ‘yes’
Investing Articles
This AI-adjacent FTSE 100 stock could be good to consider for a Stocks and Shares ISA
Investing Articles
I asked ChatGPT for the best FTSE 100 stock! Here’s what it said…
Investing Articles
Is the FTSE 100’s most valuable company still worth me buying after Q3 results?
Investing Articles
History suggests the FTSE 100 will do this after the UK Autumn Budget
Investing Articles
I asked ChatGPT what FTSE 100 shares I should buy. It said…
Investing Articles
Why I’m buying FTSE 100 shares over US growth stocks in 2026
Investing Articles
How much passive income do you need from your ISA to retire at 60?
Investing Articles
Here’s when the next stock market crash will happen, according to this billionaire investor!